Literature DB >> 7049211

Assessment of drug therapy in inflammatory bowel disease.

H J Hodgson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7049211      PMCID： PMC1427754          DOI： 10.1111/j.1365-2125.1982.tb01957.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  48 in total

1.  Oral BCG vaccine in Crohn's disease.

Authors:  W R Burnham; J E Lennard-Jones; P Hecketsweiler; R Colin; Y Geffroy
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

2.  Clinical usefulness of rectal biopsy in Crohn's disease.

Authors:  R B Hill; T H Kent; R N Hansen
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

3.  IgG and albumin turnover in Crohn's disease.

Authors:  G Bendixen; S Jarnum; J Soltoft; H Westergaard; B Weeke; M Yssing
Journal:  Scand J Gastroenterol       Date:  1968       Impact factor: 2.423

4.  Serum alpha 1-acid glycoprotein in chronic ulcerative colitis.

Authors:  W H Dearing; W F McGuckin; L R Elveback
Journal:  Gastroenterology       Date:  1969-02       Impact factor: 22.682

5.  Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study.

Authors:  P A Van Hees; H J Van Lier; P H Van Elteren; M Driessen; R A Van Hogezand; G P Ten Velde; J H Bakker; J H Van Tongeren
Journal:  Gut       Date:  1981-05       Impact factor: 23.059

6.  Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

Authors:  M Campieri; G A Lanfranchi; G Bazzocchi; C Brignola; F Sarti; G Franzin; A Battocchia; G Labo; P R Dal Monte
Journal:  Lancet       Date:  1981-08-08       Impact factor: 79.321

7.  Measuring Crohn's disease activity.

Authors:  R F Harvey; M J Bradshaw
Journal:  Lancet       Date:  1980-05-24       Impact factor: 79.321

8.  National Cooperative Crohn's Disease Study: study design and conduct of the study.

Authors:  D H Winship; R W Summers; J W Singleton; W R Best; J M Becktel; L F Lenk; F Kern
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

9.  Incidence of Crohn's disease in Cardiff between 1934-1977.

Authors:  J Mayberry; J Rhodes; L E Hughes
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

10.  Abnormalities in the apparently normal bowel mucosa in Crohn's disease.

Authors:  M J Goodman; J M Skinner; S C Truelove
Journal:  Lancet       Date:  1976-02-07       Impact factor: 79.321
View more
  5 in total

Review 1.  Health related quality of life in inflammatory bowel disease: the impact of surgical therapy.

Authors:  Konstantin Umanskiy; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

2.  Why measure C reactive protein?

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

3.  Specificity of indium-111 granulocyte scanning and fecal excretion measurement in inflammatory bowel disease--an autoradiographic study.

Authors:  A Keshavarzian; Y E Price; A M Peters; J P Lavender; N A Wright; H J Hodgson
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

4.  Assessment of disease activity in inflammatory bowel disease: a new approach using 111In granulocyte scanning.

Authors:  S H Saverymuttu; J P Lavender; H J Hodgson; V S Chadwick
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

5.  Clostridium difficile and inflammatory bowel disease.

Authors:  C Greenfield; J R Aguilar Ramirez; R E Pounder; T Williams; M Danvers; S R Marper; P Noone
Journal:  Gut       Date:  1983-08       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.